Research Technician In Vivo Cancer Immunotherap
| Posting date: | 24 March 2026 |
|---|---|
| Salary: | £36,636 to £37,694 per year |
| Additional salary information: | Full Time Fixed Term for 12 months |
| Hours: | Full time |
| Closing date: | 23 April 2026 |
| Location: | Southampton, Hampshire |
| Remote working: | On-site only |
| Company: | University of Southampton |
| Job type: | Contract |
| Job reference: | 3373626CM |
Summary
Project summary
An exciting opportunity is available to join the laboratories of Dr Ali Roghanian and Dr Salah Mansour at the University of Southampton in collaboration with MiNK Therapeutics. We are seeking a collaborative and motivated scientist to work on our new funded programme developing next-generation, off-the-shelf immunotherapies for childhood cancers.
This 21-month project will harness engineered cytotoxic invariant Natural Killer T (iNKT) cells for precision targeting of paediatric cancer neoantigens. Building on strong preliminary data, it combines mechanistic and translational immunology with bespoke in vivo models to define and exploit therapeutic candidates. The Research Assistant will lead studies on cytotoxic T cell mechanisms, oversee preclinical validation, and advance TCR-engineered iNKT platforms optimised for immunotherapy.
The role bridges basic and translational research and suits a creative scientist with interests in tumour immunology, T cell engineering, and immunotherapy. You will join a multidisciplinary team spanning immunology, with access to advanced flow cytometry and in vivo platforms.
Key responsibilities
• To work within the Mansour and Roghanian labs, and with collaborators at Southampton, LifeArc and MiNK Therapeutics.
• To design, conduct, and analyse in vitro and in vivo immunology experiments.
• To lead the optimisation and functional assessment of human T cells.
• To liaise and coordinate between project collaborators, including the industrial partner, and core facilities.
• To record analyses accurately and present results at group and collaborative meetings, and conferences.
• To contribute to dissemination of findings through publications and grant applications.
• Any other duties appropriate to the scope and grade of the post.
Essential qualifications, experience and competencies
• Degree (BSc or equivalent) in biological or biomedical sciences or equivalent experience
• Strong practical experience with core immunological assays (e.g., FACS, ELISA, T cell assays).
• Proven competence in the design and execution of experiments using mouse models of cancer.
• Ability to manage projects to timelines, supervise junior staff, and work both independently and collaboratively.
• Excellent communication and presentation skills, including at conferences.
Desirable
• Experience in engineering human T cells, viral transduction, or related approaches.
• Home Office Personal Licence.
About us
The University of Southampton offers a strong environment for translational immunology. Clinical and Experimental Sciences (CES) is a hub for infection and immunology, while the Centre for Cancer Immunology (CCI) is the UK’s first dedicated cancer immunology centre. Together, they unite expertise in T cell biology, multiomics, immunotherapy, preclinical modelling, and clinical translation, supported by an embedded Clinical Trials Unit and close links with NHS and industry partners.
How to apply
Applications must be submitted via the University of Southampton recruitment system by 6th April 2026. Interviews will be held soon after.
Applicants should provide:
• A CV
• A cover letter outlining suitability for the role
Start date: May 2026 or soon after (negotiable)
An exciting opportunity is available to join the laboratories of Dr Ali Roghanian and Dr Salah Mansour at the University of Southampton in collaboration with MiNK Therapeutics. We are seeking a collaborative and motivated scientist to work on our new funded programme developing next-generation, off-the-shelf immunotherapies for childhood cancers.
This 21-month project will harness engineered cytotoxic invariant Natural Killer T (iNKT) cells for precision targeting of paediatric cancer neoantigens. Building on strong preliminary data, it combines mechanistic and translational immunology with bespoke in vivo models to define and exploit therapeutic candidates. The Research Assistant will lead studies on cytotoxic T cell mechanisms, oversee preclinical validation, and advance TCR-engineered iNKT platforms optimised for immunotherapy.
The role bridges basic and translational research and suits a creative scientist with interests in tumour immunology, T cell engineering, and immunotherapy. You will join a multidisciplinary team spanning immunology, with access to advanced flow cytometry and in vivo platforms.
Key responsibilities
• To work within the Mansour and Roghanian labs, and with collaborators at Southampton, LifeArc and MiNK Therapeutics.
• To design, conduct, and analyse in vitro and in vivo immunology experiments.
• To lead the optimisation and functional assessment of human T cells.
• To liaise and coordinate between project collaborators, including the industrial partner, and core facilities.
• To record analyses accurately and present results at group and collaborative meetings, and conferences.
• To contribute to dissemination of findings through publications and grant applications.
• Any other duties appropriate to the scope and grade of the post.
Essential qualifications, experience and competencies
• Degree (BSc or equivalent) in biological or biomedical sciences or equivalent experience
• Strong practical experience with core immunological assays (e.g., FACS, ELISA, T cell assays).
• Proven competence in the design and execution of experiments using mouse models of cancer.
• Ability to manage projects to timelines, supervise junior staff, and work both independently and collaboratively.
• Excellent communication and presentation skills, including at conferences.
Desirable
• Experience in engineering human T cells, viral transduction, or related approaches.
• Home Office Personal Licence.
About us
The University of Southampton offers a strong environment for translational immunology. Clinical and Experimental Sciences (CES) is a hub for infection and immunology, while the Centre for Cancer Immunology (CCI) is the UK’s first dedicated cancer immunology centre. Together, they unite expertise in T cell biology, multiomics, immunotherapy, preclinical modelling, and clinical translation, supported by an embedded Clinical Trials Unit and close links with NHS and industry partners.
How to apply
Applications must be submitted via the University of Southampton recruitment system by 6th April 2026. Interviews will be held soon after.
Applicants should provide:
• A CV
• A cover letter outlining suitability for the role
Start date: May 2026 or soon after (negotiable)
Proud member of the Disability Confident employer scheme
Disability Confident
About Disability Confident
A Disability Confident employer will generally offer an interview to any applicant that declares they have a disability and meets the minimum criteria for the job as defined by the employer. It is important to note that in certain recruitment situations such as high-volume, seasonal and high-peak times, the employer may wish to limit the overall numbers of interviews offered to both disabled people and non-disabled people. For more details please go to Disability Confident.